Understanding the Obesity-Hypertension Connection: A Clinician Discussion
Caissa Troutman, MD, provides an overview of the connection between obesity and hypertension.
FDA Approves Next-Gen Noninvasive CRC Screening Test: Daily Dose
Your daily dose of the clinical news you may have missed.
False Positive Breast Cancer Screening Linked with Greater Risk of Later Diagnosis
Even after adjusting for breast density, studies reveal a significantly greater risk for a cancer diagnosis within 2 decades. A UC Davis expert offers details.
Family Caregiving for Alzheimer Disease Worth a 6-Figure Annual Salary: New Research
Supported by Otsuka, new research calculated the value of daily hours spent on basic chores and complex tasks required to support a loved one with AD.
Pharmacotherapy Recommendations for Obesity Management from the AGA: A Guideline Topline
Antiobesity medications are the next step after lifestyle interventions prove inadequate; here are the American Gastroenterological Association recommendations, at-a-glance.
GLP-1RAs May Lower Risk of Suicidal Ideation for Youth with Obesity, New Data Suggest
In a study of adolescents with obesity, those in the GLP-1RA group had a 33% lower risk of experiencing suicidal ideation or attempts compared with matched controls.
Depression, Anxiety in Youth with Chronic Pain: Daily Dose
FDA Faces Law Suit Over Sudden Removal of Tirzepatide from Drug Shortage List
Update: The FDA has told compounding pharmacies they may resume production of tirzepatide products while the agency further investigates supply.
How Likely is a False Positive Breast Cancer Screening Result? Veteran Researcher Explains
A false positive finding on a screening mammogram is fairly common, according to UC Davis biostatistician Diana Miglioretti, PhD. Here's why.
Novel DHE Nasal Spray Safe, Effective For Acute Treatment of Migraine in Long-Term Safety Trial
Use of the unique STS101 drug device combination proved safe, well tolerated, and effective with as needed use over 12 months, reported Satsuma Pharmaceuticals.
Beer and Cider Associated with Higher Risk of Gout in Both Sexes vs Other Alcohol Types
Higher alcohol intake was associated with a greater risk of gout for both sexes, but the correlation was stronger in men than women, according to a recent study.
After a False Positive Result, Screening Mammography May Not be a Priority for Some Women
The group of women least likely to return for a regular preventive screening mammogram after a false positive result surprised this primary investigator.
Sotagliflozin in Patients with Type 1 Diabetes and CKD to be Discussed at October FDA AdComm Meeting
Lexicon's sotagliflozin is on the October 31 docket for discussion by the FDA's Endocrinologic and Metabolic Drugs Advisory Committee; PDUFA goal date remains set for December 20.
Effectiveness of Suicide Care Implementation in Primary Care: Daily Dose
Elinzanetant Update: FDA Accepts Bayer NDA, Sets July 2025 PDUFA Date
The elinzanetant NDA is based on data, including long-term efficacy, from the OASIS phase 3 clinical trial program, according to Bayer.
Researcher Explains How Women Respond to a False Positive Breast Cancer Screening Result
After a false positive outcome on screening mammography, a short interval call back for repeat imaging was a significant deterrent to future screening.
RSV Mortality Higher than for Influenza B After Hospital Discharge: Daily Dose
Single vs Multiple Inhaler Triple Therapy for COPD Could Triple Adherence, Persistence: International Data
CHEST 2024: Combined data from 4 continents found consistently better adherence/persistence when COPD triple therapy was initiated with a single inhaler.
Remdesivir Plus Dexamethasone Reduces Mortality Risk among Adults Hospitalized with COVID-19
Remdesivir plus dexamethasone was associated with reduced 14- and 28-day mortality vs dexamethasone alone, according to a large study of adults hospitalized with COVID-19.
Early Identification, Treatment of COPD Reduces Exacerbations, Health Care Burden
CHEST 2024. Initial treatment for people with COPD should begin early in the disease and leads to significantly reduced risk for exacerbations and inpatient treatment.
